Variant position: 398 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 536 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SEACVGSKFWEQSVRLGSWD RGMQYSHSIITNLLYHVVGWT
Chimpanzee SEACVGSKFWEQSVRLGSWD RGMQYSHSIITNLLYHVVGWT
Mouse SEACVGSKFWEQSVRLGSWD RGMQYSHSIITNLLYHVTGWT
Pig SEACVGSKFWEQSVRLGSWD RGVQYSHSIITNLLYHVVGWT
Bovine SEACVGSKFWEQSVRLGSWD RGMRYSHSIITNLLYHVVGWT
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
40 – 536 Lysosomal acid glucosylceramidase
379 – 379 Nucleophile
379 – 379 E -> G. 1000-fold decreases of glucosylceramidase activity.
396 – 411
Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the beta-glucocerebrosidase gene in Gaucher's disease patients.
Cormand B.; Vilageliu L.; Balcells S.; Gonzalez-Duatre R.; Chabas A.; Grinberg D.;
Hum. Mutat. 7:272-274(1996)
Cited for: VARIANTS GD HIS-352 AND GLN-398;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.